Symbol Name ID |
Rarres1
retinoic acid receptor responder (tazarotene induced) 1 MGI:1924461 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Rarres1tm1.2Mhl/Rarres1+ involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss |
increased follicular lymphoma incidence | J:324270 |
Rarres1tm1.2Mhl/Rarres1tm1.2Mhl involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss |
abnormal B cell activation | J:324270 |
abnormal B cell differentiation | J:324270 | |
abnormal B cell physiology | J:324270 | |
abnormal cell physiology | J:324270 | |
abnormal plasma cell differentiation | J:324270 | |
decreased B cell apoptosis | J:324270 | |
decreased spleen germinal center number | J:324270 | |
extramedullary hematopoiesis | J:324270 | |
increased B cell proliferation | J:324270 | |
increased follicular lymphoma incidence | J:324270 | |
Rarres1tm1d(KOMP)Wtsi/Rarres1+ involves: C57BL/6N |
increased follicular lymphoma incidence | J:324270 |
Rarres1tm1d(KOMP)Wtsi/Rarres1tm1d(KOMP)Wtsi involves: C57BL/6N |
neonatal lethality, complete penetrance | J:324270 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/05/2024 MGI 6.24 |
|
|